Your browser doesn't support javascript.
loading
Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.
Clemens, Eva; van den Heuvel-Eibrink, Marry M; Mulder, Renée L; Kremer, Leontien C M; Hudson, Melissa M; Skinner, Roderick; Constine, Louis S; Bass, Johnnie K; Kuehni, Claudia E; Langer, Thorsten; van Dalen, Elvira C; Bardi, Edith; Bonne, Nicolas-Xavier; Brock, Penelope R; Brooks, Beth; Carleton, Bruce; Caron, Eric; Chang, Kay W; Johnston, Karen; Knight, Kristin; Nathan, Paul C; Orgel, Etan; Prasad, Pinki K; Rottenberg, Jan; Scheinemann, Katrin; de Vries, Andrica C H; Walwyn, Thomas; Weiss, Annette; Am Zehnhoff-Dinnesen, Antoinette; Cohn, Richard J; Landier, Wendy.
Afiliación
  • Clemens E; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Hematology and Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.
  • van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Mulder RL; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Hudson MM; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Skinner R; Department of Pediatric and Adolescent Hematology/Oncology and Children's Hematopoietic Stem Cell Transplant Unit, Great North Children's Hospital and Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Constine LS; Departments of Radiation Oncology and Pediatrics, University of Rochester Medical Center, Rochester, New York, NY, USA.
  • Bass JK; Rehabilitation Services, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Kuehni CE; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Department of Pediatrics, Children's University Hospital of Bern, University of Bern, Bern, Switzerland.
  • Langer T; Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany.
  • van Dalen EC; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Bardi E; Department of Pediatrics and Adolescent Medicine, Kepler Universitätsklinikum, Linz, Austria.
  • Bonne NX; University of Lille, CHU Lille, Otology and Otoneurology, Lille, France.
  • Brock PR; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Brooks B; Rehabilitation Services, St Jude Children's Research Hospital, Memphis, TN, USA; Audiology and Speech Pathology Department, British Columbia's Children's Hospital, Vancouver, BC, Canada; School of Audiology and Speech Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Carleton B; Pharmaceutical Outcomes Programme, British Columbia's Children's Hospital, Vancouver, BC, Canada; Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Caron E; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Chang KW; Department of Otolaryngology, Stanford University, Palo Alto, CA, USA.
  • Johnston K; Kids Cancer Centre, Sydney Children's Hospital, High Street, Randwick, NSW, Australia.
  • Knight K; Department of Pediatric Audiology, Child Development and Rehabilitation Center, Doernbecher Children's Hospital, Oregon Health and Science University, Portland, OR, USA.
  • Nathan PC; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
  • Orgel E; Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Prasad PK; Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, USA; Division of Pediatric Hematology/Oncology, Children's Hospital of New Orleans, New Orleans, LA, USA.
  • Rottenberg J; Department of Otolaryngology and Head and Neck Surgery, St Ann's University Hospital Brno, Masaryk University, Brno, Czech Republic.
  • Scheinemann K; Division of Pediatric Hematology/Oncology, Hospital for Children and Adolescents, Cantonal Hospital Aarau, Aarau, Switzerland; Division of Pediatric Hematology/Oncology, University for Children's Hospital Basel, Basel, Switzerland; Division of Pediatric Hematology/Oncology, McMaster Children's Hospi
  • de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Hematology and Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.
  • Walwyn T; Department of Pediatric and Adolescent Oncology, Perth Children's Hospital, Nedlands, WA, Australia; School of Medicine, University of Western Australia, Perth, WA, Australia.
  • Weiss A; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Am Zehnhoff-Dinnesen A; Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University of Münster, Münster, Germany.
  • Cohn RJ; Kids Cancer Centre, Sydney Children's Hospital, High Street, Randwick, NSW, Australia; School of Women's and Children's Health, University of New South Wales Medicine, Sydney, NSW, Australia.
  • Landier W; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, AL, USA. Electronic address: wlandier@peds.uab.edu.
Lancet Oncol ; 20(1): e29-e41, 2019 01.
Article en En | MEDLINE | ID: mdl-30614474
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Atención a la Salud / Supervivientes de Cáncer / Ototoxicidad / Neoplasias / Antineoplásicos Tipo de estudio: Etiology_studies / Guideline / Screening_studies Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Atención a la Salud / Supervivientes de Cáncer / Ototoxicidad / Neoplasias / Antineoplásicos Tipo de estudio: Etiology_studies / Guideline / Screening_studies Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos